Trial Profile
Efficacy and tolerance of gemtuzumab ozogamicin in refractory acute myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2015 New trial record